Skip to main content
Faiz Anwer, MD, Oncology, Cleveland, OH, Banner - University Medical Center Tucson

FaizAnwerMD

Oncology Cleveland, OH

Associate Professor, Medicine, University of Arizona College of Medicine

Dr. Anwer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Anwer's full profile

Already have an account?

Summary

  • Dr. Faiz Anwer is an oncologist in Cleveland, OH and is affiliated with Cleveland Clinic Taussig Cancer Center. He specializes in hematologic oncology.

Education & Training

  • University of Arizona College of Medicine-Tucson
    University of Arizona College of Medicine-TucsonFellowship, Hematology and Medical Oncology, 2009 - 2012
  • UPMC Medical Education
    UPMC Medical EducationResidency, Internal Medicine, 2004 - 2007
  • Rawalpindi Medical College
    Rawalpindi Medical CollegeClass of 1998

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2018 - 2024
  • OH State Medical License
    OH State Medical License 2018 - 2023
  • AZ State Medical License
    AZ State Medical License 2007 - 2024
  • PA State Medical License
    PA State Medical License 2004 - 2008
  • WA State Medical License
    WA State Medical License Active through 2014
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • External Validation of the Impede VTE Risk Score in Newly Diagnosed Multiple Myeloma (MM) Patients
    Faiz Anwer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Depth of Pre-Treatment Immunoparesis Is an Important Prognostic Factor for Survival in Relapsed Multiple Myeloma
    Faiz Anwer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Implementation of Outpatient High-Dose Cytarabine (HiDAC) for AML: Evaluation of the Impact of Transitioned Outpatient Chemotherapy in an Oncology Care Model Setting
    Faiz Anwer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Join now to see all

Lectures

  • Pomalidomide Based Regimens for Treatment of Relapsed Multiple Myeloma: A Systematic Review and Meta-Analysis of Clinical Trials 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Gene Therapy for Thalassemia and Sickle Cell Anemia Poses Acceptable Toxicity and Efficacy: Clinical Outcomes in Forty-Seven Cases 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • A Network Meta-Analysis of Clinical Trials Assessing Induction Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia Among Young Adults 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Join now to see all

Press Mentions

  • Antibody Treatment Holds Promise in Treating Patients with Relapsed or Refractory Light-Chain Amyloidosis
    Antibody Treatment Holds Promise in Treating Patients with Relapsed or Refractory Light-Chain AmyloidosisFebruary 26th, 2019
  • Rapunzel Syndrome: Everything You Need to Know About the 'Hairy' Disorder
    Rapunzel Syndrome: Everything You Need to Know About the 'Hairy' DisorderOctober 8th, 2016
  • ASH 2018: Dec 1-4
    ASH 2018: Dec 1-4December 1st, 2017
  • Join now to see all

Professional Memberships

Hospital Affiliations